Malignant Melanoma Archive - Seite 8 von 19 - IOZK

Melanoma immunotherapy using mature DCs expressing the constitutive proteasome

2013-06-24/in Dendritic Cells, International Publications, Malignant Melanoma /von 2013-06-24 / J. Clin. Invest. 2013 Jul;123(7):3135-45

Biochemical and immunologic markers in patients with metastatic melanoma treated with chemotherapy and dendritic cell vaccine.

2013-06-04/in Dendritic Cells, International Publications, Malignant Melanoma /von 2013-06-04 / J Clin Oncol 31, 2013 (suppl; abstr e20042)

Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients.

2013-06-03/in Dendritic Cells, International Publications, Malignant Melanoma /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3040)

The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses

2012-12-15/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-12-15 / Cancer Immunol. Immunother. 2013 Apr;62(4):761-72

Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial

2012-08-07/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-08-07 / Oncol. Rep. 2012 Oct;28(4):1131-8

Autologous dendritic cell vaccine (ADCV) in combination with plasmapheresis (PP) and cyclophosphamide (Cy) in patients with disseminated melanoma: A phase II study.

2012-06-04/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr e13059)

CD40 ligand/interferon-γ matured DC immunization with gp100 antigen HLA class I A *0201 restricted peptides in patients with newly diagnosed metastatic melanoma.

2012-06-02/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2525)

Adjuvant dendritic cell (DC)-based vaccine therapy of melanoma patients.

2012-06-02/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2524)

Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

2012-03-20/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-03-20 / Cancer Immunol. Immunother. 2012 Oct;61(10):1791-804

The dermis as a portal for dendritic cell-targeted immunotherapy of cutaneous melanoma

2012-01-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-01-01 / Curr. Top. Microbiol. Immunol. 2012;351:181-220